APP and early-onset autosomal dominant Alzheimer disease: PME was able to modulate mechanisms associated with the development of Alzheimer’s disease: The accumulation of beta amyloid (Aβ was reduced by modulating APP (amyloid precursor protein) processing in vitro [10] and to prevent Aβ-induced increase of thiobarbituric acid reactive substances and cognitive deficits in mice [11].